Analyst Conference Summaries

Biotechnology Investor Aids

Cidara Therapeutics
CDTX

conference date: November 10, 2021 press release only.

Coverage of Cidara conferences has not yet begun, though I started buying the stock in March 2021.

Cidara Therapeutics: Rezafungin Data Could Bring Value [Seeking Alpha, July 20, 2021]

2021
Cidara Therapeutics Q1 2021 Press Release Cidara Therapeutics Q2 2021 Press Release Cidara Therapeutics Q3 2021 Press Release  
May 13, 2021 Aug. 12, 2021 Nov. 10, 2021  

Cidara Therapeutics (CDTX) is a clinical-stage biotechnology company specializing in therapies for viral and fungal infections.

Cidara Therapeutics web site


 

Search

More Analyst Conference Pages:

 AGEN
 AGIO
 ALNY
 ALXN
 AMAT
 AMGN
 APRE
 ARWR
 BIIB
 BMY
 CLDX
 DRNA
 EPZM
 GILD
 GLYC
 ILMN
 INO
 IONS
 ISRG
 MCHP
 MRNA
 PLX
 REGN
 RNA
 SGEN
 VBLT
 VSTM
 WBA
       

Disclaimer: My analyst summaries may include both condensations of statements made by company representatives and my own analysis. They are not covered by any warranty. I cannot guarantee anything said by company representatives is true. I try not to make errors, but it is possible. These are my personal notes which I share with other investors and which I use as the basis of my blog and Seeking Alpha articles.

Copyright 2021 William P. Meyers